<DOC>
	<DOCNO>NCT02847546</DOCNO>
	<brief_summary>The primary objective study collect data confirm performance safety True™ Flow Valvuloplasty Perfusion Catheter dilatation aortic valve preparation Transcatheter Aortic Valve Implantation ( TAVI ) .</brief_summary>
	<brief_title>Evaluation BARD® True™ Flow Valvuloplasty Perfusion Catheter Aortic Valve Dilatation</brief_title>
	<detailed_description>The BARD® True™ Flow Valvuloplasty Perfusion Catheter Study prospective , single-center , non-randomized , single-arm observational study intend collect data confirm performance safety BARD® True™ Flow Valvuloplasty Perfusion Catheter ( True™ Flow catheter ) use dilatation aortic valve preparation Transcatheter Aortic Valve Implantation ( TAVI ) . This study conduct conformance Declaration Helsinki , applicable national privacy law , European , national regulation International Organization Standardization ( ISO ) requirement ( ISO 14155:2011 ( E ) ) .</detailed_description>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>The subject voluntarily provide write informed consent prior collection studyspecific data performance studyspecific procedure use Informed Consent Form ( ICF ) review approve Ethics Committee ( EC ) site . The subject male nonpregnant female ≥ 18 year old . The subject undergoing TAVI treatment aortic stenosis . The subject annulus diameter treat available size device , accordance Instructions For Use ( IFU ) . The patient unable unwilling provide write informed consent . The patient know allergy sensitivity contrast medium adequately premedicated . The patient previous aortic valve replacement . The patient know congenital aortic valve abnormality ( e.g. , bicuspid aortic valve ) . The patient echocardiographic evidence intracardiac mass , thrombus . The patient vascular condition make insertion endovascular access aortic valve impossible . The patient another medical condition , , opinion Investigator , may cause him/her confound data interpretation , associate life expectancy insufficient allow completion study procedure . The subject currently participate investigational drug , biologic , another device study complete study treatment clinically interfere objective study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>